| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2021―Mrz―08 |
Potential for the Use of Adamantanes for the Prevention and Treatment of the Neurological Complications of COVID-19 |
Roger F Butterworth |
| 2 |
[GO] |
2021―Mrz―08 |
Potential for the Repurposing of Adamantanes for the Treatment of Covid-19 |
Roger F Butterworth |
| 3 |
[GO] |
2021―Mrz―08 |
Repurposing of Adamantanes with Transmitter Receptor Antagonist Properties for the Prevention/Treatment of COVID-19 |
SR Brenner |
| 4 |
[GO] |
2021―Mrz―08 |
Lysosomotropic Action of Amantadine: Basis for Treatment of COVID-19 |
SP Smieszek |
| 5 |
[GO] |
2021―Mrz―08 |
Adamantanes for the Prevention of COVID-19: A Review of Case Reports |
Cortes A Borra |
| 6 |
[GO] |
2021―Mrz―08 |
Repurposing of Adamantanes for the Treatment of COVID-19: Rationale and Perspectives |
Roger F Butterworth |
| 7 |
[GO] |
2021―Mrz―08 |
The Sars-Cov-2 Viroporin E and its Interaction with Amantadine an Analysis |
Aranda Abreu GE |
| 8 |
[GO] |
2021―Mrz―08 |
Amantadine for the Treatment of SARS-Cov-2: Case Report |
GE Aranda-Abreu |
| 9 |
[GO] |
2020―Dez―07 |
Lysosomotropic Action of Amantadine: Basis for Treatment of COVID-19 |
|
| 10 |
[GO] |
2020―Dez―07 |
Potential for the Use of Adamantanes for the Prevention and Treatment of the Neurological Complications of COVID-19 |
|
| 11 |
[GO] |
2020―Dez―07 |
Adamantanes for the Prevention of COVID-19: A Review of Case Reports |
|
| 12 |
[GO] |
2020―Dez―07 |
Repurposing of Adamantanes for the Treatment of COVID-19: Rationale and Perspectives |
|
| 13 |
[GO] |
2020―Dez―07 |
The Sars-Cov-2 Viroporin E and its Interaction with Amantadine an Analysis |
|
| 14 |
[GO] |
2020―Dez―07 |
Amantadine for the Treatment of SARS-Cov-2: Case Report |
|
